Expert view: The OXYCAPT™ multilayer plastic vial and syringe provides solutions for problems with current primary containers

Posted: 26 October 2020 | | No comments yet

There are several problems with existing primary containers; for example, glass suffers from breakage, delamination, etc., and plastic is an insufficient oxygen and ultraviolet (UV) barrier.

These issues, especially with glass, have been highlighted by the US Food and Drug Administration (FDA), who suggest they have caused more than 50 recalls. To address this, many suppliers have launched alternative plastic vials and syringes, but the oxygen barrier has, so far, not met the customers’ demands.

    To read this expert view in full, please complete the form below:


    This specialist content is provided to you free-of-charge thanks to the kind support of Mitsubishi Gas Chemical

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related topics

    Related organisations